Page 2,842«..1020..2,8412,8422,8432,844..2,8502,860..»

Stem cells in ovaries can produce healthy eggs

Posted: February 28, 2012 at 3:26 am

WASHINGTON — For 60 years, doctors have believed women were born with all the eggs they'll ever have. Now Harvard scientists are challenging that dogma, saying they've discovered the ovaries of young women harbor very rare stem cells capable of producing new eggs.

Danica Patrick Crashes in Daytona Debut Oscar Winner Octavia Spencer Reveals Her Dream Date The Bachelor: Who Is Best for Ben Flajnik? Nicole Richie: My Daughter Doesn't Know She's Famous Natalie Portman & Benjamin Millepied: Are They Secretly Married?

If Sunday's report is confirmed, harnessing those stem cells might one day lead to better treatments for women left infertile because of disease — or simply because they're getting older.

"Our current views of ovarian aging are incomplete. There's much more to the story than simply the trickling away of a fixed pool of eggs," said lead researcher Jonathan Tilly of Harvard's Massachusetts General Hospital, who has long hunted these cells in a series of controversial studies.

Tilly's previous work drew fierce skepticism, and independent experts urged caution about the latest findings.

A key next step is to see whether other laboratories can verify the work. If so, then it would take years of additional research to learn how to use the cells, said Teresa Woodruff, fertility preservation chief at Northwestern University's Feinberg School of Medicine.

Still, even a leading critic said such research may help dispel some of the enduring mystery surrounding how human eggs are born and mature.

"This is going to spark renewed interest, and more than anything else it's giving us some new directions to work in," said David Albertini, director of the University of Kansas' Center for Reproductive Sciences. While he has plenty of questions about the latest work, "I'm less skeptical," he said.

Scientists have long taught that all female mammals are born with a finite supply of egg cells, called ooctyes, that runs out in middle age. Tilly, Mass General's reproductive biology director, first challenged that notion in 2004, reporting that the ovaries of adult mice harbor some egg-producing stem cells. Recently, Tilly noted, a lab in China and another in the U.S. also have reported finding those rare cells in mice.

But do they exist in women? Enter the new work, reported in the journal Nature Medicine.

First Tilly had to find healthy human ovaries to study. He collaborated with scientists at Japan's Saitama Medical University, who were freezing ovaries donated for research by healthy 20-somethings who underwent a sex-change operation.

Tilly also had to address a criticism: How to tell if he was finding true stem cells or just very immature eggs. His team latched onto a protein believed to sit on the surface of only those purported stem cells and fished them out. To track what happened next, the researchers inserted a gene that makes some jellyfish glow green into those cells. If the cells made eggs, those would glow, too.

"Bang, it worked — cells popped right out" of the human tissue, Tilly said.

Researchers watched through a microscope as new eggs grew in a lab dish. Then came the pivotal experiment: They injected the stem cells into pieces of human ovary. They transplanted the human tissue under the skin of mice, to provide it a nourishing blood supply. Within two weeks, they reported telltale green-tinged egg cells forming.

That's still a long way from showing they'll mature into usable, quality eggs, Albertini said.

And more work is needed to tell exactly what these cells are, cautioned reproductive biologist Kyle Orwig of the University of Pittsburgh Medical Center, who has watched Tilly's work with great interest.

But if they're really competent stem cells, Orwig asked, then why would women undergo menopause? Indeed, something so rare wouldn't contribute much to a woman's natural reproductive capacity, added Northwestern's Woodruff.

Tilly argues that using stem cells to grow eggs in lab dishes might one day help preserve cancer patients' fertility. Today, Woodruff's lab and others freeze pieces of girls' ovaries before they undergo fertility-destroying chemotherapy or radiation. They're studying how to coax the immature eggs inside to mature so they could be used for in vitro fertilization years later when the girls are grown. If that eventually works, Tilly says stem cells might offer a better egg supply.

Further down the road, he wonders if it also might be possible to recharge an aging woman's ovaries.

The new research was funded largely by the National Institutes of Health. Tilly co-founded a company, OvaScience Inc., to try to develop the findings into fertility treatments.

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Continue reading here:
Stem cells in ovaries can produce healthy eggs

Posted in Stem Cell Videos | Comments Off on Stem cells in ovaries can produce healthy eggs

Stem Cells in Ovaries May Give Women More Eggs

Posted: February 28, 2012 at 3:26 am

Contrary to the belief that women are born with a finite number of eggs, there may in fact be a way to replenish the supply, a new study suggests.

Researchers have isolated stem cells from adult human ovaries that appear to be capable of producing eggs.

ANALYSIS: Old Genes Making Hulking Ants

The new findings follow a number of recent studies that have suggested such stem cells exist in adult mice, and can give rise to healthy offspring in animals that have had their fertility destroyed by chemotherapy. However, these studies have been controversial, because they go against years of research suggesting otherwise, experts say.

In the new study, the researchers devised a more rigorous way to isolate these cells, and for the first time, suggested their existence in people.

If true, the findings could have implications for women's fertility treatments. Currently, women who choose to undergo in vitro fertilization (IVF) for infertility must endure hormone injections so doctors can retrieve eggs for fertilization, said study researcher Jonathan Tilly, director of the Vincent Center for Reproductive Biology at Massachusetts General Hospital. But if researchers could isolate egg-producing stem cells from ovaries, it might be possible to conduct that whole process outside the body, Tilly said.

"That whole program of IVF… becomes a non-necessity," Tilly said.

The study is published online Feb. 26 in the journal Nature Medicine.

Egg Stem Cells

In the new study, Tilly and colleagues isolated egg-producing stem cells from human ovary tissue by targeting a protein found on the surface of only these cells. In dishes, the cells grew into cells that had properties of human eggs. For instance, they had half the genetic material of other cells in the body.

Next, to show the stem cells could produce eggs, the researchers placed a gene into the stem cells that made them glow green, placed the stem cells into human ovarian tissue (taken during a biopsy), and grafted this tissue into mice. One to two weeks later, this tissue contained egg cells glowing green, showing they had formed from the stem cells, the researchers said.

NEWS: Stems Cells Improve Vision in Two Blind Patients

The researchers don't yet know if these egg cells could be fertilized to produce children. The United States does not allow human eggs to be fertilized for research purposes. The researchers also don't know whether these egg-producing stem cells are active throughout a woman's life, or only when they receive a particular signal, Tilly said, although the researchers have a follow-up study planned to address this question.

The number of egg-producing stem cells appear to be quite minute. In mice, they make up about 0.014 percent of all cells in the ovary, Tilly said.

Still a Controversy

"It's very novel and it's very exciting," said Dr. Sandra Carson, professor of obstetrics and gynecology, at Brown University's Women & Infants Hospital, who was not involved in the study.

"It certainly makes sense that there would be those stem cells still there," said Carson, noting men have stem cells that produce sperm throughout life.

However, other researchers say the new paper does not resolve the controversy of whether egg-producing cells exist in adult ovaries.

"I would like to see better characterization of this very small pool of cells that may be present in the ovary," said Dr. Marco Conti, professor and director of the Center for Reproductive Sciences at the University of California, San Francisco. Conti noted that some properties of the egg-producing cells described in this study do not match descriptions from previous studies.

And the paper still does not address whether these cells have any role in adult humans.

"There is no real functional evidence that this pool of cells indeed contributes to [egg formation] in the adult," Conti said.

But if these cells do in fact work in the way the researchers suspect, it might be possible to grow and mature them in an environment that resembles an ovary, Carson said.

In addition, unlike human eggs, these stem cells can be frozen without damage, Tilly said, so it may be possible to store them for future use.

Tilly is a co-founder of OvaScience, Inc, which has licensed the commercial potential of these findings for development of new fertility-enhancing procedures.

More From HealthNewsDaily.com

Read the original post:
Stem Cells in Ovaries May Give Women More Eggs

Posted in Stem Cell Videos | Comments Off on Stem Cells in Ovaries May Give Women More Eggs

Stem Cells in Women's Ovaries May Produce New Eggs, Study Finds

Posted: February 28, 2012 at 3:26 am

Contrary to the belief that women are born with a finite number of eggs, there may in fact be a way to replenish the supply, a new study suggests.

Researchers have isolated stem cells from adult human ovaries that appear to be capable of producing eggs.

The new findings follow a number of recent studies that have suggested such stem cells exist in adult mice, and can give rise to healthy offspring in animals that have had their fertility destroyed by chemotherapy. However, these studies have been controversial, because they go against years of research suggesting otherwise, experts say.

In the new study, the researchers devised a more rigorous way to isolate these cells, and for the first time, suggested their existence in people.

If true, the findings could have  implications for women's fertility treatments. Currently, women who choose to undergo in vitro fertilization (IVF) for infertility must endure hormone injections so doctors can retrieve eggs for fertilization, said study researcher Jonathan Tilly, director of the Vincent Center for Reproductive Biology at Massachusetts General Hospital. But if researchers could isolate egg-producing stem cells from ovaries, it might be possible to conduct that whole process outside the body, Tilly said.

"That whole program of IVF… becomes a non-necessity," Tilly said.

The study is published online today (Feb. 26) in the journal Nature Medicine.

Egg stem cells

In the new study, Tilly and colleagues isolated egg-producing stem cells from human ovary tissue by targeting a protein found on the surface of only these cells. In dishes, the cells grew into cells that had properties of human eggs. For instance, they had half the genetic material of other cells in the body.

Next, to show the stem cells could produce eggs, the researchers placed a gene into the stem cells that made them glow green, placed the stem cells into human ovarian tissue (taken during a biopsy), and grafted this tissue into mice. One to two weeks later, this tissue contained egg cells glowing green, showing they had formed from the stem cells, the researchers said.

The researchers don't yet know if these egg cells could be fertilized to produce children. The United States does not allow human eggs to be fertilized for research purposes. The researchers also don't know whether these egg-producing stem cells are active throughout a woman's life, or only when they receive a particular signal, Tilly said, although the researchers have a follow-up study planned to address this question.

The number of egg-producing stem cells appear to be quite minute. In mice, they make up about 0.014 percent of all cells in the ovary, Tilly said.

Still a controversy

"It's very novel and it's very exciting," said Dr. Sandra Carson, professor of obstetrics and gynecology, at Brown University's Women & Infants Hospital, who was not involved in the study.

"It certainly makes sense that there would be those stem cells still there," said Carson, noting men have stem cells that produce sperm throughout life.

However, other researchers say the new paper does not resolve the controversy of whether egg-producing cells exist in adult ovaries.

"I would like to see better characterization of this very small pool of cells that may be present in the ovary," said Dr. Marco Conti, professor and director of the Center for Reproductive Sciences at the University of California, San Francisco. Conti noted that some properties of the egg-producing cells described in this study do not match descriptions from previous studies.

And the paper still does not address whether these cells have any role in adult humans.

"There is no real functional evidence that this pool of cells indeed contributes to [egg formation] in the adult," Conti said.

But if these cells do in fact work in the way the researchers suspect, it might be possible to grow and mature them in an environment that resembles an ovary, Carson said.

In addition, unlike human eggs, these stem cells can be frozen without damage, Tilly said, so it may be possible to store them for future use.

Tilly is a co-founder of OvaScience, Inc, which has licensed the commercial potential of these findings for development of new fertility-enhancing procedures.

Pass it on:  Women's ovaries may contain stem cells that are capable of producing eggs after birth.

This story was provided by MyHealthNewsDaily, a sister site to LiveScience. Follow MyHealthNewsDaily staff writer Rachael Rettner on Twitter @RachaelRettner. Find us on Facebook.

More:
Stem Cells in Women's Ovaries May Produce New Eggs, Study Finds

Posted in Stem Cell Videos | Comments Off on Stem Cells in Women's Ovaries May Produce New Eggs, Study Finds

A.M. Vitals: Stem-Cell Experiment May Suggest Future Fertility Treatments

Posted: February 28, 2012 at 3:26 am

By Katherine Hobson

Stem-Cell Discovery: Research published in Nature Medicine suggests a way to take stem cells from a woman’s ovary and convert them into normal immature eggs that appear to be viable, the WSJ reports. While scientists say the development, if borne out, offers a potential research avenue for fertility treatments, they also caution that many obstacles remain.

Video-Game Study: Research published in Pediatrics suggests those “active” video games aren’t necessarily giving kids a lot more exercise than traditional games for sofa-sitters, Reuters reports. While the active games may slightly increase caloric burn for kids, they aren’t likely going to help them meet their daily recommended 60 minutes of activity, an outside researcher tells Reuters.

Medicaid Cuts: Washington state’s plan to cut off Medicaid payment for certain non-urgent medical services when delivered in an emergency room is riling providers, the WSJ reports. The move aims to reduce health-care costs by diverting patients to more appropriate venues for care, but physicians and hospitals say some of the procedures and tests are necessary to rule out emergency problems and that they will end up stuck with the bill, the paper says.

Trying to Treat Cachexia: Two experimental drugs to treat cachexia, the weight loss and muscle-wasting that often accompany cancer, are in late-stage clinical trials and if all goes well, could be available in two to three years, the Los Angeles Times reports. A researcher not affiliated with either of the companies developing the drugs says the hope is that the drugs will not only help cancer patients have more strength to fight their disease, but will also prolong life.

Image: iStockphoto

Read this article:
A.M. Vitals: Stem-Cell Experiment May Suggest Future Fertility Treatments

Posted in Stem Cell Treatments | Comments Off on A.M. Vitals: Stem-Cell Experiment May Suggest Future Fertility Treatments

Stem cell fertility treatments could be risky for older women

Posted: February 28, 2012 at 3:26 am

Harvard scientists are challenging traditional medical logic that dictates that women are born with a finite amount of eggs.  The scientists said they have discovered the ovaries of young women harbor rare stem cells that are in fact capable of producing new eggs.

If properly harnessed, those stem cells may someday lead to new treatments for women suffering from infertility due to cancer or other diseases – or for those who are simply getting older, according to the researchers.  Lead researcher Jonathan Tilly of Harvard's Massachusetts General Hospital has co-founded a company, OvaScience Inc., to try to develop the findings into fertility treatments.

The idea that women are born with all the egg cells – called oocytes – they’ll ever have has been called into question by past research, which found egg-producing stem cells in adult mice.

In this latest study, Harvard researchers, in collaboration with Japanese scientists, used donated frozen ovaries from 20 year olds and ‘fished out’ the purported stem cells.  

The researchers inserted a gene into the stem cells, which caused them to glow green.  If the cells produced eggs, those would glow green, too.

The researchers first watched through a microscope as new eggs grew in a lab dish.  They then implanted the human tissue under the skin of mice to provide a nourishing blood supply.  Within two weeks, they observed green-tinged cells forming.

While the work of the Harvard scientists does show potential, there are still questions as to whether the cells are capable of growing into mature, usable eggs.

If so, researchers said, it might be possible one day to use the stem cells in order to grow eggs in lab dishes to help preserve cancer patients’ fertility, which can be harmed by chemotherapy.

Now, I just want to say, while this would be a remarkable discovery – if it pans out – I do have a few concerns. 

I think for specific patients in prime, childbearing ages, who are at risk of losing their fertility for one reason or another, this could be a fruitful discovery for them.

Be that as it may, I am totally against commercializing this technology to the point where women going through menopause look at this as another way of getting pregnant.  For many, this could create incredibly high-risk pregnancies, among other medical problems.

While science is capable of great discovery and innovation – particularly in the field of stem cells – I believe that with reproductive medicine, we should move forward with great caution to minimize any risk to mother and baby.

See more here:
Stem cell fertility treatments could be risky for older women

Posted in Stem Cell Research | Comments Off on Stem cell fertility treatments could be risky for older women

Scientists urged to share data on stem cells research

Posted: February 28, 2012 at 3:26 am

By Noimot Olayiwola
Staff Reporter
Researchers and scientists in the field of both embryonic and adult stem cells research in the Middle East were yesterday urged to be more open to collaboration and networking among themselves in order to build on their already acquired and existing strengths for the betterment of the future use of stem cells in curing genetic diseases in the region.
Stem cells are ‘unspecialised’ cells that are able to divide and produce copies of themselves and having the potential to differentiate, that is, to produce other cell types in the body.
Speaking on how to further expand the scope of stem cell research in the region during a panel discussion yesterday at the ongoing Qatar International Conference on Stem Cell Science and Policy, Weill Cornell Medical College in Qatar’s Dr Jeremie Arash Rafii Tabrizi said there was the need for the region’s researchers in the field of stem cells to know each other and come together to network and form collaborations.
“I believe that each and everyone in the field within this region has built some sort of strength while conducting their individual researches, so I will suggest that we all come together to put heads together and also explore how we can benefit from our colleagues elsewhere. And if we can be more diseases-focused in our researches, I believe it is a good way to move forward,” he noted.
Making a presentation on “Stem Cell Research: From Promise to Practice”, Dr Aida al-Aqeel, of Riyadh Military Hospital’s paediatrics department, maintained that it would take a while before stem cell research can become a ‘clinical reality’.
“Despite that stem cell research is at the forefront of the need for research to cure most degenerative diseases, it will still take a long way for the stem cell research to become achievable clinically because the embryonic stem cells (ESCs) have huge therapeutic potential as they can give rise to every cell type in the body (pluripotency) as compared to adult stem cells (ASCs) from certain adult tissues that can only differentiate into a limited range of cell types,” she said.
“However, this research raises sensitive ethical and religious arguments, which are balanced against possible great benefit of such research for the patients suffering from so far incurable diseases. Serious questions remain about safety,” she said, noting that the ability for stem cells to be expanded in culture without genetic and epigenetic abnormalities and their ability to form functional cell types in vitro and in vivo, and their immuno-compatibility with the patient still need to be studied.
“In Saudi Arabia, for the last five years, the Stem Cell Therapy Programme has been established at King Faisal Specialist Hospital and Research Centre with the launch of 10 projects. Embryonic stem cell therapy for genetics metabolic disorders is one of the most promising modalities for the therapy and prevention of mentally and physically handicapped in children,” she said while sharing experiences from the KSA.
She pointed out how Islamic teachings make embryonic stem cell research and therapeutic technique, and its modality of treatment permissible as well as the Islamic perspectives about reproductive/therapeutic cloning.
“The focus of research community should be on developing human research capacity in both ASCs and ESCs. Each type of research will take time to mature. The ethical debate will need to produce acceptable policy and regulatory compromises so that the regulatory burden can be reduced and investors’ risk aversion can be overcome,” she stated.
Other speaker during the session moderated by WCMC-Q dean Dr Javaid Sheikh were Professor Hossein Baharvand from the Royan Institute for Reproductive Biomedicine Stem Cell Biology and Technology on “A Chemical Approach to Efficient Generating Embryonic and Germline-derived Pluripotent Stem Cells”.

Read more from the original source:
Scientists urged to share data on stem cells research

Posted in Stem Cell Research | Comments Off on Scientists urged to share data on stem cells research

Nature: BrainStorm's NurOwn™ Stem Cell Technology Offers Hope for Treating Huntington Disease

Posted: February 28, 2012 at 3:26 am

NEW YORK & PETACH TIKVAH--(BUSINESS WIRE)--

BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI.OB - News), a leading developer of adult stem cell technologies and therapeutics, announced today that the prestigious Nature Reviews Neurology, a Nature Publishing Group Journal, highlighted recently published preclinical research results indicating that stem cells, generated with Brainstorm’s NurOwn™ technology, provide hope for Huntington disease's patients.

In the preclinical studies conducted by leading scientists including Professors Melamed and Offen of Tel Aviv University and originally reported in Experimental Neurology, patients' bone marrow derived mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) that were transplanted into an animal model of Huntington disease showed therapeutic benefits.

Addressing the role of these MSC-NTF cells in Huntington disease, Professor Daniel Offen explains, "the premise is that such cells can be transplanted safely into affected areas of the brain, and thereby serve as vehicles for delivering neurotrophic factors." Offen expressed his hope that this cell-based therapy may eventually progress to the clinic.

BrainStorm is currently conducting a Phase I/II Human Clinical Trial for Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrig’s disease at the Hadassah Medical center. Initial results have shown that Brainstorm’s NurOwn™ therapy is safe, does not show any significant treatment-related adverse events, and have also shown certain signs of beneficial clinical effects.

Follow this link for the Research Highlights page in Nature Reviews Neurology (starts Feb. 28th ): http://www.nature.com/nrneurol/journal/vaop/ncurrent/index.html

To read the Original Article entitled ‘Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: A potential therapy for Huntington's disease’ by Sadan et al. follow this link: http://www.sciencedirect.com/science/article/pii/S0014488612000295

About BrainStorm Cell Therapeutics, Inc.

BrainStorm Cell Therapeutics Inc. is a biotech company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases. The company, through its wholly owned subsidiary Brainstorm Cell Therapeutics Ltd., holds rights to develop and commercialize the technology through an exclusive, worldwide licensing agreement with Ramot (www.ramot.org) at Tel Aviv University Ltd., the technology transfer company of Tel-Aviv University. The technology is currently in a Phase I/II clinical trials for ALS in Israel.

Safe Harbor Statement

Statements in this announcement other than historical data and information constitute "forward-looking statements" and involve risks and uncertainties that could cause BrainStorm Cell Therapeutics Inc.'s actual results to differ materially from those stated or implied by such forward-looking statements, including, inter alia, regarding safety and efficacy in its human clinical trials and thereafter; the Company's ability to progress any product candidates in pre-clinical or clinical trials; the scope, rate and progress of its pre-clinical trials and other research and development activities; the scope, rate and progress of clinical trials we commence; clinical trial results; safety and efficacy of the product even if the data from pre-clinical or clinical trials is positive; uncertainties relating to clinical trials; risks relating to the commercialization, if any, of our proposed product candidates; dependence on the efforts of third parties; failure by us to secure and maintain relationships with collaborators; dependence on intellectual property; competition for clinical resources and patient enrollment from drug candidates in development by other companies with greater resources and visibility, and risks that we may lack the financial resources and access to capital to fund our operations. The potential risks and uncertainties include risks associated with BrainStorm's limited operating history, history of losses; minimal working capital, dependence on its license to Ramot's technology; ability to adequately protect its technology; dependence on key executives and on its scientific consultants; ability to obtain required regulatory approvals; and other factors detailed in BrainStorm's annual report on Form 10-K and quarterly reports on Form 10-Q available at http://www.sec.gov. The Company does not undertake any obligation to update forward-looking statements made by us.

Go here to read the rest:
Nature: BrainStorm's NurOwn™ Stem Cell Technology Offers Hope for Treating Huntington Disease

Posted in Stem Cell Research | Comments Off on Nature: BrainStorm's NurOwn™ Stem Cell Technology Offers Hope for Treating Huntington Disease

StemCells, Inc. to Participate in Qatar International Conference on Stem Cell Science and Policy 2012

Posted: February 28, 2012 at 3:26 am

NEWARK, Calif., Feb. 27, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM - News) today announced that it will participate in the Qatar International Conference on Stem Cell Science and Policy, which is being held in Qatar from February 27 to March 1, 2012. The Company, which is the leader in development of cell-based therapeutics for central nervous system disorders, was specifically invited by the conference's sponsors, the State of Qatar and Amir of Qatar His Highness Sheikh Hamad bin Khalifa Al-Thani, as well as the James A. Baker III Institute for Public Policy of Rice University, and is the only company to be invited.

Ann Tsukamoto, Ph.D., StemCells' Executive Vice President, Research and Development, will make a presentation on the clinical translation of human neural stem cells. StemCells was the first company to receive authorization from the US Food and Drug Administration to conduct a clinical trial of purified human neural stem cells, and the Company is currently conducting two clinical trials with a third anticipated to start later this year. Dr. Tsukamoto will also be the moderator of the panel session on neurological disorders, which is scheduled to be held on March 1 from 9:30 a.m. to 11:00 a.m. Arabian Standard Time (AST).

In addition, Irving Weissman, M.D., Chairman of StemCells' Scientific Advisory Board, will make a keynote presentation to the conference on Tuesday, February 28 at 9:00 a.m. AST. Dr. Weissman, who is Virginia and Daniel K. Ludwig Professor of Cancer Research, Professor of Pathology and Professor of Developmental Biology at the Stanford School of Medicine, and Director of the Stanford Institute of Stem Cell Biology and Regenerative Medicine, will speak on normal and neoplastic stem cells. Dr. Weissman will also participate in a panel discussion on the opportunities and challenges for stem cell research, and will moderate a panel discussion on pluripotent stem cells.

The Qatar International Conference on Stem Cell Science and Policy will bring together more than 400 international participants from industry, academia and public policy, including leading experts from each of these sectors. The conference's objectives are to showcase the latest stem cell research from around the world, while promoting discussion and awareness of scientific, ethical and regulatory issues related to this innovative and dynamic field.

About StemCells, Inc.

StemCells, Inc. is engaged in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery. The Company's lead therapeutic product candidate, HuCNS-SC(R) cells (purified human neural stem cells), is currently in development as a potential treatment for a broad range of central nervous system disorders. The Company recently completed a clinical trial in Pelizaeus-Merzbacher disease (PMD), a fatal myelination disorder in children, and expects to report the trial results soon. The Company is also conducting a Phase I/II clinical trial in chronic spinal cord injury, and expects to initiate a Phase I/II clinical trial in dry age- related macular degeneration in the near future. In addition, the Company is pursuing preclinical studies of its HuCNS-SC cells in Alzheimer's disease. StemCells also markets stem cell research products, including media and reagents, under the SC Proven(R) brand, and is developing stem cell-based assay platforms for use in pharmaceutical research, drug discovery and drug development. Further information about StemCells is available at http://www.stemcellsinc.com.

The StemCells, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7014

Apart from statements of historical fact, the text of this press release constitutes forward-looking statements within the meaning of the U.S. securities laws, and is subject to the safe harbors created therein. These statements include, but are not limited to, statements regarding the clinical development of its HuCNS-SC cells; the Company's ability to commercialize drug discovery and drug development tools; and the future business operations of the Company. These forward-looking statements speak only as of the date of this news release. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. Such statements reflect management's current views and are based on certain assumptions that may or may not ultimately prove valid. The Company's actual results may vary materially from those contemplated in such forward-looking statements due to risks and uncertainties to which the Company is subject, including those described under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 and in its subsequent reports on Form 10-Q and Form 8-K.

Visit link:
StemCells, Inc. to Participate in Qatar International Conference on Stem Cell Science and Policy 2012

Posted in Stem Cell Research | Comments Off on StemCells, Inc. to Participate in Qatar International Conference on Stem Cell Science and Policy 2012

New Stem Cell Research Could End the Hard Stop of Female Fertility

Posted: February 28, 2012 at 3:26 am

A long-held belief about women and fertility is that each woman has a set amount of eggs in her lifetime and that when those eggs are depleted at menopause, so are her chances at having a biological child. However, research out of Massachusetts General Hospital questioning that view. Using stem cells taken from human ovaries, scientists have produced early-stage eggs, which brings up all sorts of questions about possible new methods for treating infertility. Nicholas Wade, writing in the New York Times, adds, "The ability to isolate stem cells from which eggs could be cultivated would help not only with fertility but also with biologists’ understanding of how drugs and nutrition affect the egg cells."

RELATED: Gecko Foot Glue; When Alcohol Is a Health Food

Jonathan Tilly, the director of Mass General's Vincent Center for Reproductive Biology and leader of the new research, had reported in 2004 that ovarian stem cells in mice could create new eggs "similar to how stem cells in male testes produce sperm throughout a man’s life." His new study attempted to prove this with humans. Researchers took healthy ovaries from patients having sex reassignment surgery, and injected stem cells from the ovaries into human ovarian tissue grafted under the skin of mice: "Within two weeks, early stage human follicles with oocytes had formed." Ryan Flinn writes in Bloomberg Businessweek that this could potentially point at "new ways to aid fertility by delaying when the ovaries stop functioning." 

RELATED: The Super Discriminating Powers of Ovulating Women

Dr. Tilly has long been a proponent of the belief that women might be able to produce new eggs, and has said the 50-year belief otherwise is based on lack of evidence rather than on data proving that it's impossible. In 2005, he reported that women have a "hidden reserve of cells in the bone marrow that constantly replenish the ovaries with new eggs," though other researchers have not been able to confirm his finding. 

RELATED: Richard Dawkins Gets into a Comments War with Feminists

Along with opening new doors to understanding the incredibly complex human egg cell, this new research could eventually have very practical implications for the 10 percent of child-bearing age women in the U.S. who have fertility problems. More philosophically, it opens up a new way of thinking about the hard-stop in women's lives for having kids. While fertility technologies like in-vitro and egg freezing are happening to some extent, Tilly's team is exploring the way this new knowledge could improve in-vitro -- IVF involves a limited number of eggs -- and also looking into possibility of developing an ovarian stem-cell bank with eggs that could be "cryogenically frozen and thawed without damage, unlike human eggs." 

“The problem we face with IVF is we don’t have many eggs to work with,” said Tilly. “These cells are renewable. If we are successful -- and it’s a big if -- in generating functioning eggs from these cells, we can generate as many eggs as we need to on a per patient basis.”

Researchers warn that there's a ways to go before there are any real applications to this, if ever. Female reproduction expert David Albertini said it's still unclear whether the egg cells yielded actually could be used in human fertility. Cells grown in laboratories are more likely to develop abnormalities; even if they are proven viable, it's a given that there will be numerous social and political aspects that factor in down the road. Nonetheless, evidence that women's eggs may not be the finite commodity we all thought they were seems poised to make a huge impact across many aspects of contemporary life. What would if mean, for instance, if the old ticking "biological clock" no longer applied -- or applied to women and men more equivalently? 

RELATED: Your Daughter's Science Role Model: A Cartoon Space Chimp

As Tilly said in a recording released to the press, "If we can guide the process correctly, I think it opens up a chance that sometime in the future, we might get to the point of actually having an unlimited source of human eggs. A woman could come in, have a small biopsy taken from her ovary for us to retrieve these cells. Once we get these cells out, we can take a hundred of them and make a million of them. If we can get to the stage of generating functional human eggs outside the body, it would rewrite essentially human assisted reproduction."

RELATED: Lubrication Can Be Good, Caffeine Can Be Bad

Brave new world? Maternity ages stretching into the 50s and 60s? Or simply another step toward the prediction some have made that sex will be just a recreational activity in another 10 years?

Go here to see the original:
New Stem Cell Research Could End the Hard Stop of Female Fertility

Posted in Stem Cell Research | Comments Off on New Stem Cell Research Could End the Hard Stop of Female Fertility

Egg-making stem cells found in adult ovaries

Posted: February 27, 2012 at 5:02 pm

It’s time to rewrite the textbooks. For 60 years, everyone from high-school biology teachers to top fertility specialists has been operating under the assumption that women are born with all the eggs they will ever produce, with no way to replenish that supply. But the discovery of human egg-producing stem cells, harvested from the ovaries of six women aged 22 to 33, puts that dogma in doubt.

The work, published online in Nature Medicine1 by Jonathan Tilly and colleagues at Massachusetts General Hospital in Boston, parallels the findings of a Shanghai-based group2 that isolated similar stem cells from mice in 2009. However, both this and Tilly’s earlier work in mice3 remained controversial, with many experts sceptical that such stem cells existed.

“This is unequivocal proof that not only was the mouse biology correct, but what we proposed eight years ago was also correct — that there was a human population of stem cells in young adult tissue,” says Tilly.

To address the doubts, Tilly’s team began by developing a more sensitive method for identifying and collecting mouse ovarian stem cells. Their method, based on a technique called fluorescence-activated cell sorting (FACS), attaches a fluorescently labelled antibody to a protein, Ddx4, that is present on the outer surface of the stem cells but not on the surface of the later-stage egg cells or oocytes. The FACS instrument lines up cells in single file and sorts them one by one, separating the labelled ones from the rest; it also gets rid of dead or damaged cells, such as oocytes, in which internal Ddx4 might become accessible to the antibody. This method is more selective than previous isolation methods, which did not get rid of such cells.

Once the team confirmed that it had isolated mouse ovarian stem cells by this method, it set its sights on reproductive-age human ovaries. Yasushi Takai, a former research fellow in Tilly’s lab and now a reproductive biologist at Saitama Medical University in Japan, supplied frozen whole ovaries removed from sex-reassignment patients, all young women of reproductive age. “It was 9 November when we did the first human FACS sort and I knew immediately that it had worked,” says Tilly. “I cannot even put into words the excitement — and, to some degree, the relief — I felt.”

The cells they pulled out, called oogonial stem cells (OSCs), spontaneously generated apparently normal immature oocytes when cultured in the lab. To look at the development of the putative human OSCs in a more natural environment, the team labelled the cells with green fluorescent protein to make them traceable, and injected them into fragments ofadulthumanovarian tissue, which were then transplanted under the skin of mice. After one to two weeks of growth, the OSCs had formed green-glowing cells that looked like oocytes and that also expressed two of the genetic hallmarks of this cell type.

“There’s no confirmation that we have baby-making eggs yet, but every other indication is that these cells are the real deal — bona fide oocyte precursor cells,” says Tilly. The next step, to test whether the human OSC-derived oocytes can be fertilized and form an early embryo, will require special considerations — namely, private funding to support the work in the United States (federal funding cannot by law be used for any research that will result in the destruction of a human embryo, whatever the source of the embryo) or a licence from the UK Human Fertilisation and Embryology Authority to do the work with collaborators in the United Kingdom.

“I’ve seen these cells and how they behave. They’re convincing and impressive.”

Evelyn Telfer, a reproductive biologist at the University of Edinburgh, UK, was once sceptical of the mouse work, but has become a believer. “I’ve visited [Tilly’s] lab, seen these cells and how they behave. They’re convincing and impressive,” she says. Telfer, who studies the maturation of human eggs in vitro, will work with Tilly to try to grow the OSC-derived eggs to the point at which they are ready for fertilization.

She notes that there’s still no evidence that the OSCs form new eggs naturally in the body. However, if they could be coaxed in a dish to make eggs that could successfully be used for in vitro fertilization (IVF), it would change the face of assisted reproduction.

“That’s a huge ‘if’,” admits Tilly. But, he continues, it could mean an unlimited supply of eggs for women who have ovarian tissue that still hosts OSCs. This group could include cancer patients who have undergone sterilizing chemotherapy, women who have gone through premature menopause, or even those experiencing normal ageing. Tilly says that follow-up studies have confirmed that OSCs exist in the ovaries of women well into their 40s.

In addition, growing eggs from OSCs in the lab would allow scientists to screen for hormones or drugs that might reinvigorate these cells to keep producing eggs in the body and slow down women’s biological clocks. “Even if you could gain an additional five years of ovarian function, that would cover most women affected by IVF,” notes Tilly.

Continued here:
Egg-making stem cells found in adult ovaries

Posted in Stem Cells | Comments Off on Egg-making stem cells found in adult ovaries

Page 2,842«..1020..2,8412,8422,8432,844..2,8502,860..»